These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29151576)

  • 1. Mapping the sugar dependency for rational generation of a DNA-RNA hybrid-guided Cas9 endonuclease.
    Rueda FO; Bista M; Newton MD; Goeppert AU; Cuomo ME; Gordon E; Kröner F; Read JA; Wrigley JD; Rueda D; Taylor BJM
    Nat Commun; 2017 Nov; 8(1):1610. PubMed ID: 29151576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the structural dynamics of the CRISPR-Cas9 RNA-guided DNA-cleavage system by coarse-grained modeling.
    Zheng W
    Proteins; 2017 Feb; 85(2):342-353. PubMed ID: 27936513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guide RNA functional modules direct Cas9 activity and orthogonality.
    Briner AE; Donohoue PD; Gomaa AA; Selle K; Slorach EM; Nye CH; Haurwitz RE; Beisel CL; May AP; Barrangou R
    Mol Cell; 2014 Oct; 56(2):333-339. PubMed ID: 25373540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleic Acid-Dependent Conformational Changes in CRISPR-Cas9 Revealed by Site-Directed Spin Labeling.
    Vazquez Reyes C; Tangprasertchai NS; Yogesha SD; Nguyen RH; Zhang X; Rajan R; Qin PZ
    Cell Biochem Biophys; 2017 Jun; 75(2):203-210. PubMed ID: 27342128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
    Yang H; Patel DJ
    Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9 Structures and Mechanisms.
    Jiang F; Doudna JA
    Annu Rev Biophys; 2017 May; 46():505-529. PubMed ID: 28375731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STRUCTURAL BIOLOGY. A Cas9-guide RNA complex preorganized for target DNA recognition.
    Jiang F; Zhou K; Ma L; Gressel S; Doudna JA
    Science; 2015 Jun; 348(6242):1477-81. PubMed ID: 26113724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Reconstitution and Crystallization of Cas9 Endonuclease Bound to a Guide RNA and a DNA Target.
    Anders C; Niewoehner O; Jinek M
    Methods Enzymol; 2015; 558():515-537. PubMed ID: 26068752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time observation of DNA target interrogation and product release by the RNA-guided endonuclease CRISPR Cpf1 (Cas12a).
    Singh D; Mallon J; Poddar A; Wang Y; Tippana R; Yang O; Bailey S; Ha T
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5444-5449. PubMed ID: 29735714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-CAS9 D10A nickase target-specific fluorescent labeling of double strand DNA for whole genome mapping and structural variation analysis.
    McCaffrey J; Sibert J; Zhang B; Zhang Y; Hu W; Riethman H; Xiao M
    Nucleic Acids Res; 2016 Jan; 44(2):e11. PubMed ID: 26481349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.
    Sternberg SH; Redding S; Jinek M; Greene EC; Doudna JA
    Nature; 2014 Mar; 507(7490):62-7. PubMed ID: 24476820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A G-quadruplex motif at the 3' end of sgRNAs improves CRISPR-Cas9 based genome editing efficiency.
    Nahar S; Sehgal P; Azhar M; Rai M; Singh A; Sivasubbu S; Chakraborty D; Maiti S
    Chem Commun (Camb); 2018 Mar; 54(19):2377-2380. PubMed ID: 29450416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.
    Fu Y; Sander JD; Reyon D; Cascio VM; Joung JK
    Nat Biotechnol; 2014 Mar; 32(3):279-284. PubMed ID: 24463574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance.
    Pausch P; Müller-Esparza H; Gleditzsch D; Altegoer F; Randau L; Bange G
    Mol Cell; 2017 Aug; 67(4):622-632.e4. PubMed ID: 28781236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational control of DNA target cleavage by CRISPR-Cas9.
    Sternberg SH; LaFrance B; Kaplan M; Doudna JA
    Nature; 2015 Nov; 527(7576):110-3. PubMed ID: 26524520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric Guides Probe and Enhance Cas9 Biochemical Activity.
    Kartje ZJ; Barkau CL; Rohilla KJ; Ageely EA; Gagnon KT
    Biochemistry; 2018 May; 57(21):3027-3031. PubMed ID: 29746102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guide RNA engineering for versatile Cas9 functionality.
    Nowak CM; Lawson S; Zerez M; Bleris L
    Nucleic Acids Res; 2016 Nov; 44(20):9555-9564. PubMed ID: 27733506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Targeting by a Minimal CRISPR RNA-Guided Cascade.
    Hochstrasser ML; Taylor DW; Kornfeld JE; Nogales E; Doudna JA
    Mol Cell; 2016 Sep; 63(5):840-51. PubMed ID: 27588603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage.
    Jiang F; Taylor DW; Chen JS; Kornfeld JE; Zhou K; Thompson AJ; Nogales E; Doudna JA
    Science; 2016 Feb; 351(6275):867-71. PubMed ID: 26841432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.